Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
The patient took the second dose of Vivotif one day after the first dose; Case reference number US-BN-2024-001741 is a spontaneous case report initially received from a consumer via Med Communications (reference number USBAV24-0608) on 01-Apr-2024 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 30-Mar-2024, the patient took the first dose of Vivotif (batch number: unknown), at unknown dose, orally, for typhoid immunization. On 31-Mar-2024, one day after the first dose of Vivotif, as reported the patient woke up on Sunday morning super sleepy and thought it was Monday and the patient took the second dose of Vivotif (batch number: unknown), at unknown dose, orally (explicitly coded as 'inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A female patient of unspecified age took a second dose of Vivotif one day after the first dose for typhoid immunization, which is considered as inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human factor. The case is non-serious.; Sender's Comments: A female patient of unspecified age took a second dose of Vivotif one day after the first dose for typhoid immunization, which is considered as inappropriate schedule of vaccine administered. No associated adverse events were reported. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human factor. The case is non-serious.
Comments: None